Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases
- 15 February 2008
- Vol. 26 (18) , 2284-2296
- https://doi.org/10.1016/j.vaccine.2008.01.022
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccinesArchives of Disease in Childhood, 2007
- Carbohydrate based vaccinesFEBS Letters, 2006
- Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135Vaccine, 2005
- Bacterial polysaccharide–protein conjugate vaccinesBritish Medical Bulletin, 2004
- Evaluation of meningococcal C oligosaccharide conjugate vaccines by size‐exclusion chromatography/multi‐angle laser light scatteringBiotechnology and Applied Biochemistry, 2002
- Effect of O Acetylation of Neisseria meningitidis Serogroup A Capsular Polysaccharide on Development of Functional Immune ResponsesInfection and Immunity, 2002
- Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C StrainsInfection and Immunity, 2001
- Refined structure of monomelic diphtheria toxin at 2.3 Å resolutionProtein Science, 1994
- Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and CVaccine, 1992
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957